Condition
Coronary Stent Restenosis
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 1 (1)
Trial Status
Recruiting2
Unknown1
Terminated1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07316504Not ApplicableRecruiting
Optimal Strategy to Correct Stent underexpAnsion in Resistant Lesions
NCT04862052Not ApplicableRecruitingPrimary
Optimal Treatment for Coronary Drug Eluting Stent In-stent Restenosis
NCT00244647Phase 1Terminated
A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis
NCT00226525Not ApplicableUnknownPrimary
Effect of Metal Skin Sensitivity on Restenosis After Stent Implantation
Showing all 4 trials